Chapter
Chapter 2. The Prevalence of Asymptomatic Diabetes in Human Atherosclerosis
Chapter 3. A Search for Macroangiopathy in Patients with Latent Diabetes
Chapter 4. Angiopathy and Neuropathy in Mild Juvenile Diabetes
Chapter 5. The Role of Insulin in the Development of Atherosclerosis
Discussion and Conclusions
Chapter 6. Effect of Insulin on Lipid Metabolism of Human Arteries
Chapter 7. Glucose Lipogenesis in Rabbit Aorta in Relation to Age, Degree of Atherosclerosis, and the Presence of Insulin
Relations between Total Glucose Lipogenesis, Cellularity, and Age
Formation of Phospholipids from Glucose As Related to Cellularity and Age
The Formation of Triglycéride
Relation to Atherosclerosis
Chapter 8. Hypertriglyceridemia in Early Diabetes
Chapter 9. Altered Carbohydrate and Lipid Metabolism and Coronary Heart Disease among Men in Tecumseh, Michigan
Chapter 10. Insulin, Glucose and Lipid Levels in Mild Diabetics in Relation to Complications
Chapter 11. Studies in the Functional Properties of Vascular Mucopolysaccharides
Chapter 12. Proline Hydroxylase in Injury-Induced Arteriosclerosis
Chapter 13. Polyol Pathway Activity in Aorta
Chapter 14. Diabetic Macroangiopathy: Blood Flow and Radiological Studies
Chapter 15. Genetic Transmission of Vasculopathy in KK Mice
Chapter 16. The Metabolism of the Isolated Renal Glomerulus and Its Basement Membranes
Chapter 17. Serum Glycoprotein Disturbances and Their Rheological Effects in Diabetes Mellitus
Chapter 18. Biochemical Properties of Human Glomerular Basement Membrane in Normal and Diabetic Kidneys
Chapter 19. Biochemistry of the Glomerular Basement Membrane in Diabetes
Chapter 20. Growth Hormone and Diabetic Angiopathy
The Growth Hormone Abnormality in Diabetes Mellitus
The Nature of the Growth Hormone Abnormality in Diabetes
Other Studies on Plasma Growth Hormone in Diabetes
Hypophysectomy in Long-Term Diabetes
The Growth Hormone Hypothesis
Chapter 21. Comparative Metabolie and Clinical Studies of Sexual Ateliotic Dwarfs and Diabetics
Lipoprotein Patterns in Serum
Chapter 22. Plasma Levels of Growth Hormone and Glucagon in Diabetic Patients and Relatives of Diabetic Patients
Plasma Levels of Growth Hormone
Plasma Levels of Growth Hormone and Glucagon
Chapter 23. Plasma Epinephrine and Plasma Norepinephrine Concentrations in Early Diabetes
Chapter 24. Microangiopathy and Early Diabeticlike Sugar Tolerances in Animals with Induced Thyroid Immunity
Chapter 25. Microangiopathy in the Experimentally Diabetic Animal
Chapter 26. Vascular Changes Accompanying Dysmetabolism in Rabbits
Chapter 27. Microvascular Alterations in Chronically Streptozotocin-Diabetic Rats
Chapter 28. Ultrastructure of Glomerular Lesions in KK Mice
Chapter 29.Related Factors in the Progression of Microangiopathy in KK Mice
Chapter 30. Microangiopathy in Animals with Spontaneous Diabetes
Chapter 31. Retinal and Renal Microangiopathy in Carp with Spontaneous Diabetes Mellitus
Chapter 32. Diabetic Basement Membranelike Changes Demonstrable in Peripheral Blood Lymphocytes
Conclusion and Working Hypothesis
Chapter 33. Ophthalmoscopic Findings and Changes in Hormonal and Metabolic Parameters in "Protodiabetes"
Patients, Examinations and Methods
Chapter 34. Kidney Structural Abnormalities in Early Diabetes
The Peripheral Glomerular Basement Membrane
Chapter 35. The Capillaries of South African Diabetics in Perspective
Chapter 36. Diabetic Microangiopathy: Electron Microscope Findings in Human Muscle
Basement Membrane Width in Diabetes
Absence of Microangiopathy in Ateliotic Dwarfs
Retinal Microangiopathy as the Initial Sign of Diabetes Mellitus
Modified Methods of Measuring Average Basement Membrane Width
Chapter 37. Capillary Basement Membrane Thickness in Early Diabetes
Chapter 38. Early Capillary Basement Membrane Changes in Subjects with Diabetes Mellitus
Chapter 39. Deterioration of Tolerance to Glucose and Progression of the Microangiopathy: Effect of Treatment (Preliminary Report)
Chapter 40. Microvascular Changes in Early Diabetes Mellitus
Chapter 41. Basement Membrane Thickening in Latent Diabetes
Chapter 42. The Microvascular Complications ofEarly Diabetes in the Pima Indians
Chapter 43. Role of Sorbitol Pathway in Neuropathy
Effect of Therapy on Nerve Carbohydrate Content
Chapter 44. The Polyol Pathway in the Neuropathy of Early Diabetes
Chapter 45. Nervous Abnormalities in Early Diabetes
Nerve Function during Anoxia
Motor Nerve Conduction Velocity (MNCV)
Chapter 46. Ultrastructural Pathology of Peripheral Nervous System in Early Diabetes
Chapter 47. Neurological Findings in Chemical Diabetes
Chapter 48. Neurological Changes in Early Diabetes
Chapter 49. Clinical Features of Peripheral Neuropathy Associated with Hypoglycemia
Peripheral Neuropathy in Exogenous Hyperinsulinism
Peripheral Neuropathy in Endogenous Hyperinsulinism
Part IV: EFFECT OF TREATMENT
Chapter 50. Effect of Hypophysectomy and Growth Hormone Treatment on the Composition of Canine Aorta
Chapter 51. Cardiovascular Complications in Diabetics
Chapter 52. Therapy of Early Diabetes: The University Group Diabetes Program
Chapter 53. Borderline Diabetics and Their Response to Tolbutamide
Effect of Treatment with Oral Compounds
Weight and Blood Sugar Changes
Chapter 54. Long-Term Treatment of Patients with Abnormal Intravenous Glucose Tolerance after Myocardial Infarction
Chapter 55. Vascular Disease in Diabetes and the Effect of Oral Antidiabetic Agents
Pathogenesis of Vascular Disease
Effect of Oral Antidiabetic Agents: The University Group Diabetes Program
Joslin Clinic Studies with Oral Agents
Chapter 56. Treatment of Chemical Diabetes with Chlorpropamide and the Associated Mortality
Chapter 57. Progress Report on the Prophylactic Use of Oral Hypoglycemie Drugs in Asymptomatic Diabetes: Neurovascular Studies
Chapter 58. Improvement in Motor Nerve Conduction Following Treatment in Newly Diagnosed Diabetics
Chapter 59. The Effects of Metformin on Lipid-Induced Atherosclerosis
Vascular and Neurological Changes in Early Diabetes
：Advances in Metabolic Disorders, Vol. 2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
